1278379

AnazaoHealth Corporation — FEI 3011152407

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 8, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Las Vegas, NV (United States)

Citations

IDCFRDescription
136121 CFR 211.100(a)Absence of Written Procedures
145121 CFR 211.113(b)Procedures for sterile drug products
203121 CFR 211.194(a)Complete test data included in records
261921 CFR 211.198(b)(2)Complaint Investigation/Follow-Up Findings